A recent study performed by dermatologist Whitney A. High, MD, MEng, Department of Dermatology at the University of Colorado, Denver and published in the Journal of the American Academy of Dermatology advanced the growing statistical evidence of the presence of gadolinium in the systems of patients suffering from Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD), which was initially recognized as a disease in 1997. 

Given the relatively short amount of time that NSF/NSD has been on the medical radar, new facts and figures are constantly emerging, and this particular study showed that four patients of the seven total who suffered from NSF/NSD had gadolinium in their systems.  Although this is a relatively small sample, it only bolsters the alarm that’s growing within the medical community regarding the link between injecting gadolinium into patients with kidney problems to help diagnose an MRI and the subsequent side effects.

In healthy patients, gadolinium is expelled from the system in a short amount of time, but those with kidney issues are generally unable to move this chemical agent out of their bodies.  The result of this resulting prolonged exposure to the substance leads to the potential scarring of internal organs, which in turn can lead to serious injuries or even death. 

If you have suffered as a result of being injected with gadolinium, you need to contact the gadolinium lawyers at Williams Kherkher today for a free initial consultation.   You can do so by clicking the link provided or by calling the firm toll free at 866.950.9000.